retatrutide study news today The Thriving Black Market for a Powerful Weight Loss Drug Retatrutide Helped Adults With Diabetes

But, as she says, 'it didn't change the fact that nothing worked.' Following this Knudsen got roped into the team's effort to improve a native GLP-1 peptide licensed from MGH

Although these drugs have been used to treat type 2 diabetes for nearly two decades, it was not until 2021 that the US FDA approved them for treating obesity

In the pivotal STEP 1 trial, patients receiving semaglutide 2.4mg weekly achieved average weight loss of 14.9% over 68 weeks

Many people rush this

Stacking it with another GLP-1 agonist like semaglutide would be redundant and increase side effects without proportional benefit

The net effect in clinical trials was improved blood sugar control, not worsened